BTG3 methylation was higher in breast cancer than normal tissues (Figure 3F, p < 0.05), N3 than N0, Luminal and Her2+ than TNBC, Her2+ than Luminal cancer patients by UALCAN (Figure 3G, p < 0.05). This evidence concerns the gene BTG3 and breast cancer.